- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04276805
Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults
April 28, 2025 updated by: University of Florida
We need better tools to both enhance brain health and improve cognitive performance in healthy brain aging so that it can be delayed, reduced, or even reversed.
The present proposal is designed to evaluate the pairing of cognitive training with a non-invasive neurostimulation technology that has shown promise in both increasing neuroplasticity and in enhancing cognitive performance, transcutaneous vagal nerve stimulation (tVNS).
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
7
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85721
- University of Arizona
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 90 years (Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy individuals willing to commit to study requirements
Exclusion Criteria:
- Neurological disorders to include traumatic brain injury.
- Evidence of dementia .
- Major psychiatric illness
- Unstable and chronic medical conditions.
- MRI contraindications (e.g., pregnancy, claustrophobia, metal implants that are contraindicated for MRI).
- Physical impairment precluding motor response or lying still or walking
- Hearing or vision deficits that will not allow for completion of assessments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: tVNS group
Participants will undergo cognitive training with tVNS
|
a non-invasive and safe technique that transiently enhances brain GABA and noradrenaline levels.
A program of regular mental activities purported to maintain or improve one's cognitive abilities.
|
|
Sham Comparator: Sham group
Participants will undergo cognitive training with earlobe sham
|
A program of regular mental activities purported to maintain or improve one's cognitive abilities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in working memory and processing speed contributors
Time Frame: Baseline to 2 weeks
|
The Posit Science BrainHQ
|
Baseline to 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: John Williamson, PhD, University of Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 17, 2020
Primary Completion (Estimated)
October 30, 2025
Study Completion (Estimated)
October 30, 2025
Study Registration Dates
First Submitted
February 17, 2020
First Submitted That Met QC Criteria
February 17, 2020
First Posted (Actual)
February 19, 2020
Study Record Updates
Last Update Posted (Actual)
May 1, 2025
Last Update Submitted That Met QC Criteria
April 28, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- IRB201902991
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
Synbiotic HealthMusB ResearchRecruitingHealthy Aging | Anti AgingUnited States
-
Research Centre for Natural SciencesSemmelweis University; HUN-REN Institute of Experimental MedicineActive, not recruitingHealthy Aging | Neurocognitive AgingHungary
-
Amazentis SAproDERM GmbHCompleted
Clinical Trials on Transcutaneous vagal nerve stimulation (tVNS)
-
Queen Mary University of LondonKing's College LondonWithdrawn
-
Maastricht University Medical CenterWingate Institute of NeurogastroenterologyRecruitingfMRI | Transcutaneous Vagal Nerve Stimulation (tVNS) | Nucleus of the Solitary Tract (NTS)Netherlands, United Kingdom
-
Marshall HollandNot yet recruitingAneurysmal Subarachnoid Hemorrhage | Endovascular Treatment | Vasospasm, Cerebral | Transcutaneous Vagal Nerve Stimulation (tVNS)United States
-
University of FloridaCompleted
-
Philipps University Marburg Medical CenterEuropean CommissionCompleted
-
Saima Abass TahammalAl Ain UniversityCompletedDiabetes Mellitus | Diabetic Neuropathies | Neuropathic Pain | Type2diabetesPakistan
-
Istituto Clinico HumanitasRecruitingPhysical Disability | Orthostatic Intolerance | Postural Tachycardia Syndrome | Autonomic Dysfunction | Syncope, PosturalItaly
-
Emory UniversityUS Department of Veterans AffairsRecruitingPrehypertension | Post-traumatic Stress DisorderUnited States
-
Charles Ethan Paccione, M.S., M.A.CompletedChronic Widespread Pain | FibromyalgiaNorway
-
Université de SherbrookeFonds de la Recherche en Santé du Québec; Association Pulmonaire du Quebec; Québec...CompletedDyspnea | Chronic Obstructive Pulmonary Disease SevereCanada